Chemfab Alkalis working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
94.09×94.09×79.11×61.26×75.37×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
26.31×26.31×22.92×23.95×23.78×
112.58×112.58×108.99×102.16×125.44×
7.82×7.82×−6.96×−16.95×−26.29×
−19.87×−13.60×13.95×91.98×4.52×
0.57×0.57×0.65×0.72×0.87×
−11.12×−11.12×−5.75×4.79×1.43×
1.40×1.40×0.91×2.34×0.84×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CHEMFAB₹298.00

Chemfab Alkalis Limited

· Chemicals
₹ CrorePeersPRIMOPLASTIBLENMANORGKRONOXJAYAGROGNLORDSCHLODMCCSRHHYPOLTDMcap ₹428 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Inventory Days (DIO)75.3761.2679.1194.0994.09
Receivable Days (DSO)23.7823.9522.9226.3126.31
Payable Days (DPO)125.44102.16108.99112.58112.58
Cash Conversion Cycle (days)-26.29-16.95-6.967.827.82
Working Capital Turnover4.5291.9813.95-13.60-19.87
Asset Turnover0.870.720.650.570.57
Cash Conversion (CFO/Net Income)1.434.79-5.75-11.12-11.12
CFO/EBITDA0.842.340.911.401.40
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.